Patent Assignment
Reel/Frame 069793/0367
Change of Name
Recorded: 2024-12-27
Pages: 4
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Properties
(3)
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Methods and Compositions for Daily Ophthalmic Administration of Phentolamine to Improve Visual Performance
Application:
18/209,783 →
Publication:
US 2024/0050412
Highly Pure Phentolamine Mesylate and Methods for Making Same
Application:
18/619,535 →
Publication:
US 2024/0308967
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Jul 25, 2023
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 064370/0706 →
Assignment of Assignor's Interest
Jul 25, 2023
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 064370/0720 →
Assignment of Assignor's Interest
Mar 28, 2024
From: ONICIU, DANIELA CARMEN
To: OCUPHIRE PHARMA, INC.
Reel/Frame 066937/0858 →
Assignment of Assignor's Interest
Jun 17, 2024
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 067743/0537 →
Merger
Jun 17, 2024
From: OCULARIS PHARMA, LLC.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067743/0569 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →